Method and test kit for the determination of fetal pulmonary maturity status

Claim 3

The method of claim 1 which includes centrifugally testing those test samples which are visually observed to have an optical density (OD) between the positive and negative control samples to determine fetal pulmonary maturity.

Claim 4

The method of claim 1 wherein the control samples comprise a solid agar sample in a transparent vial.

Claim 5

The method of claim 1 wherein the control sample comprises an aqueous suspension of barium sulfate prepared by the reaction of a barium salt and sulfuric acid in a transparent vial and which includes shaking the control sample suspension prior to comparing the amniotic fluid test sample with the control samples.

Claim 6

The method of claim 1 which includes comparing the control samples which are in transparent vials to the test sample which is in a transparent vial where the test sample is adjacent to or between control sample vials and all the vials are compared against a selected background.

Claim 7

The method of claim 1 wherein the positive control sample comprises about 3.0% by weight of purified agar in water and the negative control sample comprises about 0.75% by weight of purified agar in water.

Claim 8

The method of claim 6 which includes adding a coloring agent to the purified agar control sample to mimic the color of the amniotic fluid to be tested.

Claim 9

A test kit for the determination of fetal pulmonary maturity from an amniotic fluid test sample, which test kit comprises in combination: (a) a positive control sample constructed so as to mimic an optical density (OD) of about 0.80 at 650 nm which indicates fetal pulmonary maturity; and (b) a negative control sample constructed so as to mimic an optical density (OD) of about 0.50 at 650 nm which indicates fetal pulmonary immaturity whereby visually comparing the test sample with the positive and negative control samples provides an indication of fetal pulmonary maturity of a fetus.

Claim 10

A test kit for the determination of fetal pulmonary maturity from an amniotic fluid test sample, which test kit comprises in combination: (a) a positive control sample constructed so as to mimic an optical density (OD) of about 0.80 at 650 nm which indicates fetal pulmonary maturity; and (b) a negative control sample constructed so as to mimic an optical density (OD) of about 0.50 at 650 nm which indicates fetal pulmonary immaturity whereby visually comparing the test sample with the positive and negative control samples provides an indication of fetal pulmonary maturity of a fetus.

Claim 11

The test kit of claim 8 wherein the control samples comprise a solid agar sample in a transparent vial.

Claim 12

The test kit of claim 8 wherein the control samples comprise an aqueous suspension of barium sulfate prepared by the reaction of a barium salt and sulfuric acid in a transparent vial and which includes shaking the control sample suspension prior to comparing the amniotic fluid test sample with the control samples.

Claim 13

The test kit of claim 8 wherein the positive control sample comprises about 3.0% by weight of purified agar in water and the negative control sample comprises about 0.75% by weight of purified agar in water.

Claim 14

The test kit of claim 8 includes the positive and negative control samples contained in transparent vials and the test sample contained in a transparent vial, where the test sample vial is adjacent to or between the control sample vials for comparison and all the vials are compared against a selected background means.